12
Jul
2010
Posted in I - Series B, Q - 2Q10, R - ROCKY MOUNTAIN, X - Asthma, X - COPD, X - IBD, XX - CO
N30 Pharma (Boulder, CO) a preclinical-stage biopharmaceutical company focused on small molecules inhibting GSNOR for the potential treatment of asthma, COPD, inflammatory bowel disease and heart failure, closed a $10M Series B financing. Participants include Deerfield Management, Tiger Management, Bridger Capital and Swift Current Partners.
27
May
2010
05
Mar
2010
24
Feb
2010
27
Jan
2010
Posted in I - Series B, Q - 4Q09, R - NORTH EAST, X - Antiinfective, X - Asthma, X - COPD, X - Influenza, X - RSV, X - Respiratory, XX - MA
Pulmatrix (Lexington, MA) a clinical-stage biotechnology company focused on the discovery and development of therapies for the treatment and prevention of infectious (COPD, asthma, and cystic fibrosis) and progressive respiratory (influenza, ventilator acquired pneumonia and respiratory syncytial virus (RSV)) diseases, closed a $30.2M Series B financing. Participants include Arch Venture Partners, Novartis Ventures Funds,Polaris Venture [...]
20
Oct
2009
Posted in I - Series B, Q - 3Q09, R - NORTH EAST, X - COPD, X - Device (Oxygen), XX - PA
Inspired Technologies (North Huntingdon, PA) a commercial-stage medical device company focused on auto-titration of oxygen delivery for COPD patients, closed a $5.4M Series B financing. Participants have included Birchmere Ventures, Cardinal Partners, Draper Triangle Ventures and Innovation Ventures.
26
Apr
2009
Posted in I - Series C, Q - 2Q09, R - WEST, X - Asthma, X - CF, X - COPD, X - Eczema, XX - CA
17
Feb
2009
Posted in I - Series D, Q - 1Q09, R - WEST, X - Antibacterial, X - CF, X - COPD, XX - CA
Mpex Pharmaceuticals (San Diego, CA) a clinical-stage biopharmaceutical company focused on antibiotic therapy in patients with cystic fibrosis and COPD, closed a $27.5M Series D financing. Participants include Investor Growth Capital, SV Life Sciences, HBM BioVentures, Aberdare Ventures and Adams Street Partners.
01
Dec
2008
30
Nov
2008